April 25, 2024
Kasper Bødker Mejlvang Tapped as New Novo Japan Chief Novo Nordisk Pharma renewed its record in Japan sales yet again in 2023 as its core diabetes franchise continued to enjoy upbeat performances from GLP-1 agents Ozempic (semaglutide injection) and Rybelsus...read more